We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+12.04%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$925M
AUM Growth
+$139M
Cap. Flow
+$47.9M
Cap. Flow %
5.17%
Top 10 Hldgs %
61.48%
Holding
504
New
17
Increased
76
Reduced
78
Closed
18
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BR icon
226
Broadridge
BR
$20.9B
$40K ﹤0.01%
295
BX icon
227
Blackstone
BX
$107B
$39K ﹤0.01%
329
DOW icon
228
Dow Inc
DOW
$22B
$37K ﹤0.01%
1,367
+8
+0.6% +$290
MRVL icon
229
Marvell Technology
MRVL
$195B
$37K ﹤0.01%
123
GSK icon
230
GSK
GSK
$102B
$36K ﹤0.01%
685
SCHR
231
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.4B
$36K ﹤0.01%
1,444
TMO icon
232
Thermo Fisher Scientific
TMO
$230B
$36K ﹤0.01%
71
MNST icon
233
Monster Beverage
MNST
$91.8B
$35K ﹤0.01%
720
BAM icon
234
Brookfield Asset Management
BAM
$83.2B
$34K ﹤0.01%
755
D icon
235
Dominion Energy
D
$57.7B
$34K ﹤0.01%
500
GDX icon
236
VanEck Gold Miners ETF
GDX
$31B
$34K ﹤0.01%
452
SIL icon
237
Global X Silver Miners ETF NEW
SIL
$5.38B
$34K ﹤0.01%
444
AGG icon
238
iShares Core US Aggregate Bond ETF
AGG
$138B
$33K ﹤0.01%
334
GBTC icon
239
Grayscale Bitcoin Trust
GBTC
$11.6B
$32K ﹤0.01%
700
-10
-1% -$558
GEHC icon
240
GE HealthCare
GEHC
$32.4B
$32K ﹤0.01%
497
KHC icon
241
Kraft Heinz
KHC
$30.5B
$32K ﹤0.01%
1,365
+23
+2% +$531
SPYI icon
242
NEOS S&P 500 High Income ETF
SPYI
$11.6B
$32K ﹤0.01%
594
+200
+51% +$10.5K
VEEV icon
243
Veeva Systems
VEEV
$44.8B
$32K ﹤0.01%
181
-10
-5% -$1.65K
SHW icon
244
Sherwin-Williams
SHW
$83.7B
$31K ﹤0.01%
90
VRT icon
245
Vertiv
VRT
$99B
$31K ﹤0.01%
92
+7
+8% +$2.22K
QQQI icon
246
NEOS Nasdaq 100 High Income ETF
QQQI
$14.2B
$31K ﹤0.01%
549
+218
+66% +$12K
WMB icon
247
Williams Companies
WMB
$90.2B
$30K ﹤0.01%
400
HPE icon
248
Hewlett Packard
HPE
$69.3B
$29K ﹤0.01%
646
+1
+0.2% +$36
KLAC icon
249
KLA
KLAC
$229B
$29K ﹤0.01%
95
+55
+138% +$10.9K
GILD icon
250
Gilead Sciences
GILD
$181B
$28K ﹤0.01%
218

Similar funds

Roble Belko & Company's Q2 2026 Portfolio in Review

As of Q2 2026, Roble Belko & Company held 504 positions worth $925M, up 18% from $787M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Roble Belko & Company deployed $47.9M of net new capital in Q2 2026, opening 17 new positions and adding to 76 existing holdings. Its largest new stake was iShares iBonds Dec 2034 Term Corporate ETF: 57,696 shares worth $1.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, up from 94% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Schwab US TIPS ETF, an estimated $1.19M trimmed.

  • Roble Belko & Company's largest Q2 2026 buy was iShares iBonds Dec 2034 Term Corporate ETF: 57,696 shares worth $1.5M.
  • Roble Belko & Company added most to Vanguard Total Bond Market in Q2 2026, an estimated $16.6M increase.
  • Roble Belko & Company's biggest Q2 2026 reduction was Schwab US TIPS ETF, cutting an estimated $1.19M.
  • Roble Belko & Company fully exited Foster in Q2 2026, selling an estimated $140K.
  • Roble Belko & Company's ten largest holdings make up 61% of its $925M portfolio in Q2 2026.
  • Roble Belko & Company opened 17 new positions and closed 18 in Q2 2026.
  • Roble Belko & Company's portfolio value rose 18% quarter-over-quarter to $925M.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.